{"id":"W2058736678","doi":"10.1038/bjc.2012.543","title":"Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cilag; Genentech; Bayer HealthCare; Exelixis; Sanofi; Pfizer","keywords":"Sorafenib; Tolerability; Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Cumulative incidence; Incidence (geometry); Dosing; Population; Oncology; Confidence interval; Cohort; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01017477,0.000941847,0.003181515,0.001505644,0.0002237306,0.001146144,0.0004632454,0.0005394162,0.001573111],"category_scores_gemma":[0.009462176,0.0004905846,0.007454332,0.002595644,0.0002684283,0.0005145393,0.0007452236,0.000399723,0.0002678725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005829881,"about_ca_system_score_gemma":0.0005200759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002378406,"about_ca_topic_score_gemma":0.00407911,"domain_scores_codex":[0.9943107,0.003218739,0.0008701162,0.0008745257,0.0005816049,0.00014418],"domain_scores_gemma":[0.991723,0.003719642,0.002697166,0.0009984522,0.0006568577,0.0002049679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.04256558,0.0002138725,0.4847223,0.006276221,0.4188246,0.0003707532,0.0002643682,0.002733251,0.002499705,0.00007892023,0.00211979,0.03933068],"study_design_scores_gemma":[0.003731693,0.002161588,0.7844849,0.0003779558,0.2038213,0.00045925,0.0001100047,0.001215842,0.0004592673,0.0001691965,0.00293577,0.00007320868],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8881468,0.1009291,0.002712251,0.0001882894,0.0001033229,0.0002363323,0.006413305,0.00008288817,0.001187681],"genre_scores_gemma":[0.9884768,0.006914704,0.0006283232,0.0001565253,0.0001371236,0.0001493455,0.003326113,0.00002287199,0.0001882079],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01017477,"threshold_uncertainty_score":0.05380994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006884527369790601,"score_gpt":0.2310847486887122,"score_spread":0.2242002213189216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}